Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 292, Issue 29, Pages 12208-12219Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M117.792374
Keywords
-
Categories
Funding
- Oxford Protein Purification Facility
- BBSRC [BB/D52396X/1, BB/M024156/1] Funding Source: UKRI
- MRC [MR/K018779/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/D52396X/1, BB/M024156/1] Funding Source: researchfish
- Medical Research Council [MR/K018779/1] Funding Source: researchfish
Ask authors/readers for more resources
Toxoplasma gondii is an obligate, intracellular eukaryotic apicomplexan protozoan parasite that can cause fetal damage and abortion in both animals and humans. Sphingolipids are essential and ubiquitous components of eukaryotic membranes that are both synthesized and scavenged by the Apicomplexa. Here we report the identification, isolation, and analyses of the Toxoplasma serine palmitoyltransferase, an enzyme catalyzing the first and rate-limiting step in sphingolipid biosynthesis: the condensation of serine and palmitoyl-CoA. In all eukaryotes analyzed to date, serine palmitoyltransferase is a highly conserved heterodimeric enzyme complex. However, biochemical and structural analyses demonstrated the apicomplexan orthologue to be a functional, homodimeric serine palmitoyltransferase localized to the endoplasmic reticulum. Furthermore, phylogenetic studies indicated that it was evolutionarily related to the prokaryotic serine palmitoyltransferase, identified in the Sphingomonadaceae as a soluble homodimeric enzyme. Therefore this enzyme, conserved throughout the Apicomplexa, is likely to have been obtained via lateral gene transfer from a prokaryote.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available